Published in Cancer Weekly, April 26th, 2005
The Balm In Gilead is the latest of several prominent organizations to initiate educational campaigns on cervical cancer and the emerging use of HPV testing as a standard of care for screening women age 30 and older - the group most at risk of the disease.
Digene developed the only U.S. Food and Drug Administration (FDA)-approved test for high-risk types of HPV, the cause of virtually all cases of cervical cancer. The Digene HPV Test, also marketed as the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.